Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montalescot

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Clinical Cardiology|December 29, 2000
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular diseaseG Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[Vascular action of prostaglandins: atheroma, vasoconstriction and ischemia]G Montalescot
European Heart Journal|January 29, 2002
GP IIb/IIIa inhibition in primary stenting: 'do it early, make it easy'G Montalescot
Presse Medicale (Paris, France : 1983)|June 3, 1995
[Use of aspirin in coronary disease]G Montalescot
Annales De Cardiologie Et D'Angeiologie|December 1, 1991
[Focus on anticoagulants]G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 1, 1990
[Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin]G Montalescot
Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Aspirin: towards a new consensus]G Montalescot
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
IIb/IIIa inhibitors in acute myocardial infarctionG Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 24, 2006
[Present and future developments of antithrombotic agents]G Montalescot
La Revue De Medecine Interne|January 1, 1997
[New antithrombotic agents in coronary disease]G Montalescot
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Clinical Cardiology|December 29, 2000
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular diseaseG Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[Vascular action of prostaglandins: atheroma, vasoconstriction and ischemia]G Montalescot
European Heart Journal|January 29, 2002
GP IIb/IIIa inhibition in primary stenting: 'do it early, make it easy'G Montalescot
Presse Medicale (Paris, France : 1983)|June 3, 1995
[Use of aspirin in coronary disease]G Montalescot
Annales De Cardiologie Et D'Angeiologie|December 1, 1991
[Focus on anticoagulants]G Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 1, 1990
[Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin]G Montalescot
Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Aspirin: towards a new consensus]G Montalescot
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
IIb/IIIa inhibitors in acute myocardial infarctionG Montalescot
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 24, 2006
[Present and future developments of antithrombotic agents]G Montalescot
La Revue De Medecine Interne|January 1, 1997
[New antithrombotic agents in coronary disease]G Montalescot
Pageof 15